Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-22
2000-11-07
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548242, 546270, 544140, 544368, C07D49504, A61K 3142
Patent
active
061437735
ABSTRACT:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein A is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, arylC.sub.1-6 alkyl, aryl, S(O).sub.p R.sup.1, OR.sup.1 or NR.sup.1 R.sup.12 ;
REFERENCES:
patent: 5587486 (1996-12-01), Mills, et al.
Van Rhee, et al., J. Med. Chem., vol., 39, pp. 398-406, 1996.
Broughton Howard Barff
Chambers Mark Stuart
Durette Philippe L.
Gerstl Robert
Lee Shu M.
Merck Sharp & Dohme Limited
Winokur Melvin
LandOfFree
Substituted thienobenzisoxazole derivatives for enhancing cognit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted thienobenzisoxazole derivatives for enhancing cognit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thienobenzisoxazole derivatives for enhancing cognit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1641544